The purpose ofthe Training and Career Development Program ofthe Primary Immune Deficiency Treatment Consortium (PIDTC) is to provide career development that will enhance educafion at the clinical postdoctoral level. By training investigators specifically in the area of PID, the cadre of physician-scienfists involved in elucidating the pathogenesis ofthese disorders and developing and applying improved therapies will be augmented. Clinical invesfigators caring for pafients with PID require a complex set of skills, including knowledge of immune reconstitufion and transplant immunology, diagnosis and medical management of pafients with PID, and expertise in hematology, infecfious diseases, genefics and critical care of ill pafients undergoing hematopoietic cell transplantafion (HCT). They also need to familiarize and interactwith PID Pafient Advocacy Groups. The PIDTC brings together specialists from North America and provides a unique platform to train new investigators in the course of disseminating knowledge to providers, patients and families. The goal of PIDTC training grants is to provide support for research at the level ofthe clinical post-doctoral fellow. Our experience with the first four years of awardees reinforces much of what we plan for the next cycle. We have seen the benefits of networking and formal presentations and propose to enhanceihat type of participafion. We have also noted the challenges faced by those who plan an academic career but this is an especially acute issue in the field of PIDs, where the study of rare diseases often requires a network of invesfigators, a difficult proposifion for junior faculty.
The Specific Aims of this Program are to (1) select the highest quality candidates for training support in Primary Immune Deficiency research, (2) incorporate the supported Fellows into PIDTC activities to enhance their education and networking opportunities, and (3) continue to track the outcome of training of supported fellows, based on scientific publications and career advancement. The PIDTC provides a network of committed invesfigators with specific expertise in the biology, diagnosis and treatment of PIDs, and will serve as an important training ground for emerging investigators. The structure ofthe PIDTC consortium will facilitate the development of junior invesfigators studying immune deficiencies.

Public Health Relevance

The PIDTC Training program is focused on providing small research grants to support fellows and junior faculty in research in primary immune deficiencies (PIDs) and to promote their academic careers. The Training program sfimulates interest in PIDs and encourages participation in all aspects ofthe PIDTC.

Agency
National Institute of Health (NIH)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54AI082973-06
Application #
8890309
Study Section
Special Emphasis Panel (ZTR1)
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
Long-Boyle, Janel R; Savic, Rada; Yan, Shirley et al. (2015) Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use. Ther Drug Monit 37:236-45
Haddad, Elie; Allakhverdi, Zoulfia; Griffith, Linda M et al. (2014) Survey on retransplantation criteria for patients with severe combined immunodeficiency. J Allergy Clin Immunol 133:597-9
Shearer, William T; Dunn, Elizabeth; Notarangelo, Luigi D et al. (2014) Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol 133:1092-8
Dvorak, Christopher C; Hassan, Amel; Slatter, Mary A et al. (2014) Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. J Allergy Clin Immunol 134:935-943.e15
Lee, Yu Nee; Frugoni, Francesco; Dobbs, Kerry et al. (2014) A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol 133:1099-108
Pai, Sung-Yun; Cowan, Morton J (2014) Stem cell transplantation for primary immunodeficiency diseases: the North American experience. Curr Opin Allergy Clin Immunol 14:521-6
Griffith, Linda M; Cowan, Morton J; Notarangelo, Luigi D et al. (2014) Primary Immune Deficiency Treatment Consortium (PIDTC) report. J Allergy Clin Immunol 133:335-47
Medical Advisory Committee of the Immune Deficiency Foundation; Shearer, William T; Fleisher, Thomas A et al. (2014) Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol 133:961-6
Chinen, Javier; Notarangelo, Luigi D; Shearer, William T (2014) Advances in basic and clinical immunology in 2013. J Allergy Clin Immunol 133:967-76
Pai, Sung-Yun; Logan, Brent R; Griffith, Linda M et al. (2014) Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med 371:434-46

Showing the most recent 10 out of 33 publications